Table 4.
Age group (years) | RZV second-dose compliance | VVL | |||
---|---|---|---|---|---|
Lowa | Base caseb | Higha | |||
NNV for HZ | 50–59 | 7 | 6 | 6 | 23 |
60–69 | 8 | 7 | 7 | 21 | |
70–79 | 10 | 8 | 8 | 37 | |
≥ 80 | 14 | 12 | 12 | 138 | |
NNV for PHN | 50–59 | 41 | 35 | 34 | 144 |
60–69 | 39 | 33 | 32 | 127 | |
70–79 | 40 | 34 | 33 | 66 | |
≥ 80 | 40 | 35 | 34 | 137 |
NNV Number Needed to Vaccinate
aBase-case assumptions: coverage, 40%; second-dose compliance for RZV Recombinant Zoster Vaccine, VVL Varicella Vaccine Live, HZ Herpes Zoste, PHN Postherpetic Neuralgia, 95%
bLow compliance, 70%; high compliance, 100%